Literature DB >> 2106070

Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene.

T Matsugi1, K Morishita, J N Ihle.   

Abstract

Activation of the Evi-1 zinc finger gene is a common event associated with transformation of murine myeloid leukemias. To characterize the gene product, we developed antisera against various protein domains. These antisera primarily detected a 145-kilodalton nuclear protein that bound double-stranded DNA. Binding was inhibited by chelating agents and partially restored by zinc ions.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2106070      PMCID： PMC361017          DOI： 10.1128/mcb.10.3.1259-1264.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  21 in total

1.  Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors.

Authors:  M L Mucenski; B A Taylor; J N Ihle; J W Hartley; H C Morse; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias.

Authors:  D Bordereaux; S Fichelson; B Sola; P E Tambourin; S Gisselbrecht
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line.

Authors:  Y Weinstein; J N Ihle; S Lavu; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Metal-dependent folding of a single zinc finger from transcription factor IIIA.

Authors:  A D Frankel; J M Berg; C O Pabo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.

Authors:  G I Evan; D C Hancock
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

6.  Insertion and truncation of c-myb by murine leukemia virus in a myeloid cell line derived from cultures of normal hematopoietic cells.

Authors:  Y Weinstein; J L Cleveland; D S Askew; U R Rapp; J N Ihle
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

8.  Human proto-oncogene N-myc encodes nuclear proteins that bind DNA.

Authors:  G Ramsay; L Stanton; M Schwab; J M Bishop
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  Correlation of cell-surface phenotype with the establishment of interleukin 3-dependent cell lines from wild-mouse murine leukemia virus-induced neoplasms.

Authors:  K L Holmes; E Palaszynski; T N Fredrickson; H C Morse; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain.

Authors:  K H Klempnauer; A E Sippel
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598
View more
  14 in total

1.  Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.

Authors:  Xiyun Deng; Yanna Cao; Yan Liu; Fazhi Li; Kamalanathan Sambandam; Srinivasan Rajaraman; Archibald S Perkins; Alan P Fields; Mark R Hellmich; Courtney M Townsend; E Aubrey Thompson; Tien C Ko
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.

Authors:  A S Perkins; R Fishel; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

Review 3.  Zinc finger protein genes in the mouse genome.

Authors:  A Ashworth; P Denny
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

4.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors:  K Morishita; E Parganas; C L William; M H Whittaker; H Drabkin; J Oval; R Taetle; M B Valentine; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

Authors:  Kathryn E Boyd; Ying-Yi Xiao; Kai Fan; Amanda Poholek; Neal G Copeland; Nancy A Jenkins; Archibald S Perkins
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

6.  Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.

Authors:  Hiromi Yuasa; Yuichi Oike; Atsushi Iwama; Ichiro Nishikata; Daisuke Sugiyama; Archibald Perkins; Michael L Mucenski; Toshio Suda; Kazuhiro Morishita
Journal:  EMBO J       Date:  2005-05-12       Impact factor: 11.598

7.  Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.

Authors:  C Bartholomew; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.

Authors:  R Delwel; T Funabiki; B L Kreider; K Morishita; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

9.  Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.

Authors:  K Morishita; E Parganas; T Matsugi; J N Ihle
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

10.  Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Authors:  Torsten A Konrad; Anna Karger; Hubert Hackl; Ilse Schwarzinger; Irene Herbacek; Rotraud Wieser
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.